In a report released today, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Tourmaline Bio (TRML – Research Report). The ...

Truist Financial analyst Srikripa Devarakonda reiterated a Buy rating on Scholar Rock Holding (SRRK – Research Report) today. The company’s ...

Biogen Inc BIIB reported better-than-expected earnings for its fourth quarter on Wednesday. The company posted fourth-quarter ...

Analyst Srikripa Devarakonda maintains the Buy rating while lowering the price target from $220 to $210. Price Action: BIIB stock is up 4.06% at $138.85 at last check Thursday. "ACTIVE INVESTORS ...

Eli Lilly (LLY) on Tuesday launched higher doses of Zepbound, or tirzepatide, in single-dose vials and reduced the prices of two smaller doses of the weight-loss drug for self-pay patients. The ...

Jay Backstrom; President, Chief Executive Officer, Director; Scholar Rock Holding Corp Tracey Sacco; Chief Commercial Officer; Scholar Rock Holding Corp Good morning and welcome to Scholar Rock's ...

Good day, and thank you for standing by. Welcome to the Arvinas fourth-quarter 2024 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I ...

Good day, and thank you for standing by. Welcome to the Arvinas Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After this speaker’s ...

Greetings, and welcome to the Incyte Fourth Quarter 2024 and Full Year Financial and Corporate Update Conference Call and Webcast. At this time all participants are in listen-only mode. [Operator ...

Good day, and thank you for standing by. Welcome to the Arvinas fourth-quarter 2024 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I ...